Hospital Funding Watch: San Pedro General Hospital in Belize is facing delays and rising costs, with reports saying the Taiwan grant of about US$33M may fall short by over US$15M—raising the question of who pays the difference as a site visit is planned. Trade & Health Supply Chains: Taiwan’s Vice Premier Cheng Li-chiun said the U.S. has no timetable for Section 232 semiconductor tariffs, but preferential terms were already locked in under a January deal—important for Taiwan’s chip-driven health and pharma manufacturing ecosystem. Liver Disease Update: Ipsen presented late-breaking and real-world data on IQIRVO (elafibranor) for PBC, highlighting improvements in alkaline phosphatase, fatigue, and pruritus. Cancer Trial Progress: Antengene received China’s CDE endorsement to start the pivotal Phase III CLINCH-3 study of ATG-022 (CLDN18.2+ advanced gastric/GEJ cancer). Public Health Alerts: Taiwan raised Ebola travel guidance for the DRC and Uganda to Level 3, requiring 21 days of self-health monitoring for recent travelers. Heat & Health Risk: Taipei recorded its hottest May temperature on record at 38.3°C, with heat alerts issued for multiple counties—another reminder to protect vulnerable groups. Drug Safety & Forensics: Taiwan’s FDA will review whether drug testing methods need updating after rising “zombie drug” etomidate-linked impaired driving cases.